The Indian pharmaceutical sector has long been recognized as the “pharmacy of the world,” but maintaining that leadership requires constant evolution, innovation and a commitment to the highest quality standards. Reflecting this vision, the National Conference on “Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices (GMP)” was recently held at PHD House, Chandigarh, bringing together industry leaders, regulatory experts, and innovators from across the nation.
At the heart of this influential gathering was Mr. Supreet Singh, Convener of the Regional Pharmaceutical, Health & Wellness Committee, PHD Chamber of Commerce and Industry (PHDCCI), who took center stage as the Moderator for the high-impact session titled “Foundations and Strategies for Effective GMP Implementation.”
A Confluence of Knowledge, Experience & Vision
The event served as a powerful platform for dialogue between government authorities, policy experts, and pharma professionals, all driven by one shared goal – strengthening India’s pharmaceutical quality ecosystem.
In his opening remarks, Supreet Singh emphasized that Good Manufacturing Practices (GMP) are not just regulatory checkboxes but the very foundation of trust, safety, and global competitiveness in the pharmaceutical industry. He highlighted the importance of creating a culture of quality within organizations where every process, person and product aligns with ethical and scientific standards.
As moderator, Mr. Singh skillfully steered the discussion to uncover practical strategies for effective GMP implementation – from upskilling manpower and adopting digital quality systems to integrating sustainability and innovation into everyday manufacturing practices.
Key Discussion Highlights
The panel featured some of the most respected thought leaders and experts in pharmaceutical manufacturing and regulatory affairs. Together, they explored critical themes shaping the industry’s future, including:
- Modernizing Quality Systems: How automation, AI, and data analytics are reshaping compliance and real-time monitoring in pharma production.
- Training & Human Capital: The role of education and continuous professional development in ensuring that GMP principles are followed at every level of manufacturing.
- Regulatory Synergy: The importance of aligning domestic regulations with international standards to strengthen India’s global export credibility.
- Risk Management & Auditing: Innovative approaches to identifying quality risks early and maintaining consistency across manufacturing units.
- Sustainability in Pharma: The growing relevance of green manufacturing and ethical practices in a rapidly evolving market.
Under Supreet Singh’s moderation, the session maintained a dynamic balance between technical depth and actionable insight, ensuring every participant – from industry veterans to young professionals – took away practical lessons on improving quality and compliance.
Supreet Singh’s Message on Industry Leadership
Drawing from his extensive experience as Founder & CEO of Psychocare Health Pvt. Ltd. and Sehatokart.com, Supreet Singh spoke about the evolving relationship between quality assurance and brand reputation. “In today’s pharmaceutical world,” he remarked, “GMP isn’t just a regulatory necessity – it’s the foundation of credibility. The companies that invest in quality today will be the flagbearers of India’s healthcare future.”
He further underlined the need for collaboration between manufacturers, researchers and policymakers to ensure that India not only meets but sets global benchmarks in pharmaceutical excellence.
A Step Toward a Safer, Healthier Future
The National Conference concluded with a unified message – that ensuring quality in pharmaceuticals is not just the responsibility of regulators or companies, but a collective mission for every stakeholder in the ecosystem.
Participants commended PHDCCI for organizing a thought-provoking platform that fosters learning, innovation, and progress in the pharmaceutical sector. Many attendees shared that the event reinforced their belief in India’s potential to lead the world in quality manufacturing backed by science, ethics, and sustainability.
As the Convener of the Regional Pharmaceutical, Health & Wellness Committee, Supreet Singh continues to play a pivotal role in driving these conversations forward – bridging gaps between industry and regulation, and inspiring the next generation of pharma professionals to aim for uncompromised quality and global impact.
About PHDCCI’s Commitment
The PHD Chamber of Commerce and Industry continues to be a catalyst for India’s economic and industrial growth, supporting initiatives that promote innovation, compliance, and responsible business practices across all sectors. Through such national conferences, PHDCCI reaffirms its commitment to strengthening India’s pharmaceutical backbone with policies and practices that ensure global excellence.
This remarkable event once again highlighted the importance of dialogue, collaboration and leadership in shaping the future of the Indian pharmaceutical industry. Under the guidance of thought leaders like Supreet Singh, the journey toward achieving pharmaceutical excellence through Good Manufacturing Practices grows stronger each day – setting a new benchmark for quality, trust, and innovation.
